Kendall Kokora
Payments from drug & device makers
Across 157 payments — averaging $19.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$562
- AbbVie$465
- Pfizer$327
- Novo Nordisk$267
- GSK$235
- Bayer$187
- plus $969 from 22 others
What the payments were for
- Food & beverage$3,009100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 18 | $562 |
| AbbVie | 30 | $465 |
| Pfizer | 20 | $327 |
| Novo Nordisk | 16 | $267 |
| GSK | 12 | $235 |
| Bayer | 9 | $187 |
| Lilly USA, LLC | 8 | $147 |
| Boehringer Ingelheim | 5 | $90 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $88 |
| Amgen | 4 | $73 |
| Phathom Pharmaceuticals, Inc. | 3 | $70 |
| Merck | 4 | $65 |
| Esperion Therapeutics, Inc. | 4 | $62 |
| Corcept Therapeutics | 2 | $49 |
| Gilead | 2 | $47 |
| Dexcom, Inc. | 2 | $42 |
| Tolmar, Inc. | 2 | $31 |
| Inspire Medical Systems, Inc. | 2 | $31 |
| Exact Sciences | 1 | $24 |
| Globus Medical | 1 | $21 |
| ZOLL Respicardia, Inc. | 1 | $20 |
| Abbott | 1 | $18 |
| Lundbeck LLC | 1 | $18 |
| Vanda Pharmaceuticals Inc. | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,009 in reported general payments places this provider in the 85th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 15 | $112 |
| Doxycycline Hyclate | 14 | $107 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 12 | $67 |
| Azithromycin | 17 | $59 |
Paid to pharmacies, not to this prescriber.
Other family in Mesa
- Sharon MagalonaMesa$449K
- Rebecca McCollaumMesa$149K
- Angela StuffMesa$22K
- Maria Norivic SorianoMesa$15K
- Kelly MatthewsMesa$15K
- Angela GoldenMunds Park$378K
- Kimberly HallaPhoenix$332K
- Kaitlyn LouchheimScottsdale$208K
- Susan SarabiaSun City West$114K
- Lindsay CarterTucson$108K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.